Abstract
STEROID hormones alter sympathetic function and modulate responses to catecholamines1–3. The gonadal steroids, oestrogen and progesterone, can affect sympathetic response by altering catecholamine metabolism, and, in addition, they produce qualitative changes in the contractile response of smooth muscle to stimulation by adrenaline and noradrenaline4–6. The response of human oviduct and uteri from several species changes from contraction to relaxation depending upon the concentrations of gonadal steroids. Contraction, which is mediated by α-adrenergic receptors, is observed in uteri from oestrogen-treated humans or rabbits, while relaxation, a β-adrenergic response, predominates during pregnancy or with progesterone treatment. Conversion between α and β response, depending on hormonal or other environmental factors, has prompted the hypothesis that α- and β-adrenergic receptors may be interconvertible7–9. We used the radioligands 3H-dihydroergocryptine (DHE) and 125I-iodohydroxybenzylpindolol ([125I] IHYP) to quantitate α- and β-adrenergic receptors respectively in subcellular preparations of uteri from rabbits treated with oestrogen or oestrogen followed by progesterone. α-Adrenergic binding sites were three times greater in uteri from the oestrogen-treated animals in which α-adrenergic response was predominant than in uteri from animals treated with oestrogen followed by progesterone in which β-adrenergic response predominates. The number of β-adrenergic binding sites was unchanged by the different treatments and these sites were only 5% as numerous as α-adrenergic sites. These findings suggest that gonadal steroids may alter smooth muscle adrenergic response by alterations of adrenergic receptor number and do not support the hypothesis that α- and β-adrenergic receptors are simply interconvertible.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wolfe, B. B., Harden, T. K. & Molinoff, P. B. Proc. natn. Acad. Sci. U.S.A. 73, 1343–1347 (1976).
Rajerison, R., Marchetti, J., Roy, C., Bockaert, J. & Jard, S. J. biol. Chem. 249, 6390–6400 (1974).
Exton, J. H., Friedmann, N., Wong, E. H., Brineaux, J. P., Parks, C. R. & Corbin, J. D. J. biol. Chem. 247, 3579–3588 (1972).
Miller, M. D. & Marshall, J. M. Am. J. Physiol. 209, 859–865 (1965).
Miller, J. W. Ann. N.Y. Acad. Sci. 139, 788–798 (1967).
Iverson, L. L. Frontiers in Catecholamine Research, 3rd International Catecholamine Symposium, University of Strasbourg (eds Usdin, E. & Snyder, S. H.) 403 (Pergamon, New York, 1973).
Kunos, G. Br. J. Pharmac. Chemother. 59, 177–189 (1977).
Matheny, J. L. & Ahlquist, R. P. Arch. Int. Pharm. Therap. 218, 4–10 (1975).
Kunos, G., Yong, M. S. & Nickerson, M. Nature new Biol. 241, 119–120 (1973).
Giles, K. W. & Myers, A. Nature 206, 93 (1965).
Williams, L. T., Mullikin, D. & Lefkowitz, R. J. J. biol. Chem. 251, 6915–6923 (1976).
Roberts, J. M., Insel, P. A., Goldfien, R. D. & Goldfien, A. Endocrinology (in the press).
Maguire, M. E., Wiklund, R. A., Anderson, H. J. & Gilman, A. G. J. biol. Chem. 251, 1227–1231 (1976).
Brown, E. M., Aurbach, G. D., Hauser, D. & Troxler, F. J. biol. Chem. 251, 1232–1238 (1976).
Harden, T. K., Wolfe, B. B. & Molinoff, P. B. Molec. Pharmac. 12, 1–15 (1976).
Insel, P. A., Maguire, M. E., Glman, A. G., Bourne, H. R., Coffino, P. & Melmon, K. L. Molec. Pharmac. 12, 1062–1069 (1976).
Rinard, G. A., Chew, C. S. Life Sci. 16, 1507–1512 (1975).
Roberts, J. S., Barcikowski, B., Wilson, L., Skarnes, R. C. & McCracken, J. A. J. Steroid Biochemistry 6, 1091–1097 (1975).
Bülbring, E. in Drug Receptors (ed. Rang, H. P.) 1–13 (University Park Press, London, 1973).
Ueland, K., Novy, M. J. & Metcalfe, J. Am. J. Obstet. Gynec. 115, 4–10 (1973).
Elgee, N. J. Ann. Int. Med. 72, 409–418 (1970).
Spellacy, W. N., Carlson, K. L., Birk, S. A. & Schade, S. L. Metabolism 17, 496–501 (1968).
Talledo, O. E., Chesley, L. C. & Zuspan, F. P. Am. J. Obstet. Gynec. 100, 218–221 (1968).
Lehtovirta, P. J. Obstet. Gynaec. Br. Commonw. 81, 517–525 (1974).
Ciaraldi, T. & Marinetti, G. V. Biochem. Biophys. Res. Comm. 74, 984–991 (1977).
Williams, L. T., Lefkowitz, R. J., Watanabe, A. M., Hathaway, D. R. & Besch, H. R. J. biol. Chem. 252, 2787–2789 (1977).
Strittmatter, W. J., Davis, J. N. & Lefkowitz, R. J. J. biol. Chem. 252, 5478–5482 (1977).
Mickey, J. V., Tate, R., Mullikin, D. & Lefkowitz, R. J. Molec. Pharmac. 12, 409–419 (1976).
Shear, M., Insel, P. A., Melmon, K. L. & Coffino, P. J. biol. Chem. 251, 7572–7576 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ROBERTS, J., INSEL, P., GOLDFIEN, R. et al. α adrenoreceptors but not β adrenoreceptors increase in rabbit uterus with oestrogen. Nature 270, 624–625 (1977). https://doi.org/10.1038/270624a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/270624a0
This article is cited by
-
Comparison of the porcine uterine smooth muscle contractility on days 12–14 of the estrous cycle and pregnancy
Acta Veterinaria Scandinavica (2015)
-
Increased PKA activity and its influence on isoprenaline‐stimulated L‐type Ca2+ channels in the heart from ovariectomized rats
British Journal of Pharmacology (2005)
-
Raynaud’s phenomenon: Epidemiology and risk factors
Current Rheumatology Reports (2002)
-
Hormonal and local regulation of uterine activity during parturition: part II — The prostaglandin and adrenergic systems
Journal of Endocrinological Investigation (1994)
-
Does progesterone cause an irritable bladder?
International Urogynecology Journal (1993)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.